IL6 and tuberculosis: Accordingly, in peripheral blood mononuclear cells of TB patients, miR−125b plays a vital role in the development and progression of TB by reducing the IFN-γ, IL-6, TNF-α, and NF-κB levels by inhibiting the Raf1 proto−oncogene serine/threonine protein kinase (93).